Interactive Maps
Tip: Hover on a state to see its rate (and 95% C.I.). Click a state to show its counties.
Related Articles
OncLive – Clinical Oncology News, Cancer Expert Insights
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Secretory carcinoma of the salivary gland, a rare entity: An international multi‐institutional study
Cancer Cytopathology is an international cytopathology journal publishing research related to topics concerning the etiology of cancer, its diagnosis and prevention.
A systematic review on performance characteristics of FNA of renal lesions: It is time for a standardized classification system
Cancer Cytopathology is an international cytopathology journal publishing research related to topics concerning the etiology of cancer, its diagnosis and prevention.
Home Page: ESMO Real World Data and Digital Oncology
ESMO Real-World Data and Digital Oncology is the European Society for Medical Oncology’s latest peer-reviewed open access journal. It is dedicated to publishing high-quality data…
Risk, Genetics of Secondary Tumors Following CAR T-Cell Therapy Investigated | Blood Cancers Today
A single-center study compared the secondary and initial tumors and assessed vector viral integration’s role in oncogenesis.
FDA Broad Agency Announcement: Frequently Asked Questions for Oncology
FDA Broad Agency Announcement: Frequently Asked Questions for Oncology Researchers
An Overview of FDA’s Project Facilitate Oncology Expanded Access Progr
On Tuesday, December 12, 2023, CDER’s Office of Communication, Division of Drug Information (DDI) will host a webinar titled: FDA Drug Topics: An Overview of…
Sacituzumab Tirumotecan NDA for Pretreated EGFR+ NSCLC Accepted for Review in China
An NDA seeking the approval of sacituzumab tirumotecan for EGFR-mutant non–small cell lung cancer is under review by the NMPA’s CDE.